AVITA Medical (RCEL) EBITDA Margin (2019 - 2026)
AVITA Medical (RCEL) reported EBITDA Margin of -29.81% for Q2 2026, up 27.72 percentage points from -57.53% a year earlier.
Powered by 
Analysis
AVITA Medical (RCEL) EBITDA Margin (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, AVITA Medical's EBITDA Margin came in at -47.27%, up 12.76 percentage points year-over-year; for FY2025, it was -56.12%, up 30.21 percentage points from FY2024.
- EBITDA Margin has a five-year change of +239.85 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -86.33% in FY2024 (-3.20 pp), -83.13% in FY2023 (-5.85 pp), -77.28% in FY2022 (+22.51 pp) and -99.79% in FY2021.
- The Q2 2026 figure ranks as the highest quarterly EBITDA Margin in data going back to Q3 2022.
- Year over year, EBITDA Margin gained in five of the last seven quarters, with an average year-over-year change of +29.89 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q1 2025 (a gain of 92.06 percentage points); the low point was Q1 2024 (a drop of 61.27 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.71 Bn | 229.74 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 178.38 Bn | 148.81 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 161.61 Bn | 145.42 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 154.15 Bn | 134.44 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 123.21 Bn | 88.46 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 117.50 Bn | 103.61 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 67.50 Bn | 62.26 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 54.80 Bn | 51.95 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 51.78 Bn | 35.79 Bn | 1.35 Bn | 31.93% |
| 10 | AVITA Medical | 475.24 Mn | 406.92 Mn | 17.77 Mn | -29.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.81% |
| Dec 31, 2025 | -55.11% |
| Sep 30, 2025 | -50.28% |
| Jun 30, 2025 | -57.53% |
| Mar 31, 2025 | -61.07% |
| Dec 31, 2024 | -51.87% |
| Sep 30, 2024 | -69.05% |
| Jun 30, 2024 | -101.48% |
| Mar 31, 2024 | -153.13% |
| Dec 31, 2023 | -84.54% |
| Sep 30, 2023 | -66.38% |
| Jun 30, 2023 | -93.03% |
| Mar 31, 2023 | -91.86% |
| Dec 31, 2022 | -92.54% |
| Sep 30, 2022 | -61.79% |
| Jun 30, 2022 | -74.78% |
| Mar 31, 2022 | -122.55% |
| Sep 30, 2021 | -81.10% |
| Jun 30, 2021 | -44.24% |
| Mar 31, 2021 | -65.88% |
API Access
AVITA Medical EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RCEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RCEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RCEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();